8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



        Date of Report (Date of earliest event reported): August 15, 2005


                        Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)



           Delaware                     1-14120                    52-1611421
(State or other jurisdiction  (Commission File Number)         (I.R.S. Employer
        of incorporation)                                    Identification No.)


                One Jake Brown Road, Old Bridge, New Jersey 08857
               (Address of principal executive offices) (Zip Code)



       Registrant's telephone number, including area code: (732) 679-4000


                             Not Applicable
          (Former name or former address, if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:


[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)


[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))


[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))






Item 2.02.  Results of Operations and Financial Condition

On August 15, 2005,  Blonder Tongue  Laboratories,  Inc.  issued a press release
announcing its unaudited financial results for the second quarter ended June 30,
2005. A copy of the press release is attached to this Report as Exhibit 99.1 and
is incorporated herein by reference.  The information  disclosed in this report,
including  Exhibit  99.1  hereto,  is being  furnished  and  shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934.

Item 9.01.  Financial Statements and Exhibits

          (a) Not applicable


          (b) Not applicable


          (c) The following exhibits are filed herewith:


     Exhibit 99.1 Press Release dated August 15, 2005.




                                       2



                                    SIGNATURE


          Pursuant to the  requirements of the Securities  Exchange Act of 1934,
     the  Registrant  has duly  caused this report to be signed on its behalf by
     the undersigned hereunto duly authorized.

                        BLONDER TONGUE LABORATORIES, INC.



                        By:  /s/Eric Skolnik     
                             Eric Skolnik
                             Senior Vice President and Chief Financial Officer

Date: August 15, 2005





                                       3



                                  EXHIBIT INDEX


Exhibit No.           Description

Exhibit 99.1          Press Release of Blonder Tongue  Laboratories, Inc. dated
                      August 15, 2005 regarding its unaudited  financial results
                      for the second quarter ended June 30, 2005.














                                       4

EX-99

[LOGO]                                                       One Jake Brown Road
                                                                   P.O. Box 1000
                                               Old Bridge, New Jersey 08857-1000
                                           Tel: 732-679-4000   Fax: 732-679-4353


FOR IMMEDIATE RELEASE                         CONTACT:   James A. Luksch
August 15, 2005                                          Chairman and
                                                         Chief Executive Officer
                                                         (732) 679-4000



               BLONDER TONGUE REPORTS 2005 SECOND QUARTER RESULTS


OLD BRIDGE,  NEW JERSEY,  August 15, 2005 - Blonder  Tongue  Laboratories,  Inc.
(AMEX:  "BDR") today  reported net sales of  $9,408,000  for the second  quarter
2005,  as compared to net sales of  $10,917,000  reported in the second  quarter
2004.

Net loss for the  second  quarter  2005 was  $641,000,  or  ($0.08)  per  share,
compared  to a net  income of  $236,000  or $0.03  per share for the  comparable
period in 2004.

Commenting on the second quarter 2005 results,  James A. Luksch, Chief Executive
Officer,  said, "After having such a positive first quarter,  the second quarter
sales performance is disappointing. Our net sales were $18,677,000 for the first
six months of 2005 as compared to $19,446,000  for the same period in 2004. Last
year's net sales were favorably impacted by the recognition of $745,000 of sales
revenues relating to products shipped in prior years.  Taking that into account,
our  six-month  sales are  relatively  flat  compared  to last  year.  As stated
previously,  our primary  goals in 2005 are to reduce slow moving  inventory and
improve our sales momentum. These goals are still attainable."


Founded  in 1950,  Blonder  Tongue  Laboratories  is a  leading  U.S.  designer,
manufacturer,  and  supplier  of  a  comprehensive  line  of  broadband  systems
equipment and technical  engineering  services for Voice, Video and Data service
providers.  With Blonder Tongue's optimized technologies,  simplified deployment
and  qualified  technical  assistance,   the  service  provider  reduces  costs,
increases   customer   satisfaction  and  increases   profitability.   For  more
information regarding Blonder Tongue or its products, please visit the Company's
Web site at  www.blondertongue.com  or contact  the  Company  directly  at (732)
679-4000.

"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995: The information set forth above includes "forward-looking"  statements and
accordingly,  the cautionary  statements  contained in Blonder  Tongue's  Annual
Report and Form 10-K for the year ended  December 31, 2004 (See Item 1: Business
and Item 7:  Management's  Discussion  and Analysis of Financial  Condition  and
Results of Operations and Risk  Factors),  and other filings with the Securities
and  Exchange  Commission  are  incorporated  herein  by  reference.  The  words
"believe", "expect",  "anticipate",  "project", and similar expressions identify
forward-looking statements. Readers are cautioned not to place undue reliance on
these forward-looking statements, which reflect management's analysis only as of
the date hereof.  Blonder  Tongue  undertakes no  obligation to publicly  revise
these  forward-looking  statements to reflect events or circumstances that arise
after the date  hereof.  Blonder  Tongue's  actual  results  may differ from the
anticipated  results  or  other  expectations   expressed  in  Blonder  Tongue's
"forward-looking" statements.

                                     -MORE-











                        Blonder Tongue Laboratories, Inc.
                    Consolidated Summary of Operating Results
                      (in thousands, except per-share data)
                                   (unaudited)


                                 Three months ended     Six months ended
                                      June 30,              June 30,
                                 -------------------  ------------------------
                                 2005        2004       2005           2004

Net sales                         $9,408     $10,917    $18,677     $19,446
Gross profit                       2,859       3,080      5,386       6,021
Earnings (loss) from
  operations                        (341)        247       (944)        125
Net earnings (loss)                 (641)        236     (1,531)       (161)
Net earnings (loss) per share:
   Basic                          $(0.08)      $0.03     $(0.19)     $(0.02)
                                  $(0.08)      $0.03     $(0.19)     $(0.02)
Diluted
Weighted average shares
  outstanding:
   Basic                           8,015       8,002      8,015       7,999
   Diluted                         8,015       8,026      8,015       7,999






                       Consolidated Summary Balance Sheets
                                 (in thousands)


                                         June 30, 2005         December 31, 2004
                                          (unaudited)
                                       -------------------     -----------------
Current assets                               $17,084               $16,006
Property, plant, and equipment, net            6,058                 6,214
Total assets                                  37,942                38,156
Current liabilities                            9,873                 5,403
Long-term liabilities                          2,677                 5,830
Stockholders' equity                          25,392                26,923

Total liabilities and stockholders'
  equity                                     $37,942               $38,156




                                       2